EUVIMEDEUVIMED entdecken
Leserbrief

Regarding the risk factors of rituximab‐induced thrombocytopenia in patients with autoimmune bullous diseases

Jiangling Zheng iD

The Journal of Dermatology · 2024

DOI: 10.1111/1346-8138.17262 ↗

Kurz gefasst

Leserbrief in der Zeitschrift The Journal of Dermatology, 2024. Verfasst von Jiangling Zheng. Beteiligte Einrichtung: Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Rituximab, Thrombocytopenia, Skin Diseases, Vesiculobullous. Die Arbeit nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RituximabThrombocytopeniaSkin Diseases, VesiculobullousHumansRisk FactorsAutoimmune DiseasesImmunologic FactorsFemaleMaleAgedMiddle Aged

Substanzen

RituximabImmunologic Factors

Autor:innen und Institutionen

  • Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China.

ORCID-Profile: Jiangling Zheng

Zitieren

APA

Zheng, J. (2024). Regarding the risk factors of rituximab‐induced thrombocytopenia in patients with autoimmune bullous diseases. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17262

Vancouver

Zheng J. Regarding the risk factors of rituximab‐induced thrombocytopenia in patients with autoimmune bullous diseases. The Journal of Dermatology. 2024. doi:10.1111/1346-8138.17262

BibTeX
@article{Zheng2024,
  author = {Zheng, Jiangling},
  title = {Regarding the risk factors of rituximab‐induced thrombocytopenia in patients with autoimmune bullous diseases},
  journal = {The Journal of Dermatology},
  year = {2024},
  doi = {10.1111/1346-8138.17262}
}
Kostenlos starten →